Back

Fesoterodine  Prolonged-Release Tablets NEW

4mg & 8mg

Urology

details

Fesoterodine is indicated for the treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

  • ATC4: G04BD
  • Strengths: 4mg, 8mg
  • Dosage form: Prolonged-Release Tablets
  • Out-licensing is offered for all international markets

 

* Product availability is subject to patent restrictions in countries where applicable patents are in effect